TUESDAY, March 7, 2023 (HealthDay News) — U.S. Federal health officials have issued recall notices for two more brands of eyedrops. In the latest round of recalls, the U.S. Food and Drug Administration posted notices after the companies voluntarily pulled several lots of their eyedrops from the market. These recallsContinue Reading

MONDAY, March 6, 2023 (HealthDay News) — Consumers have been using a common over-the-counter oral decongestant known as phenylephrine for years, but that may not continue much longer. The U.S. Food and Drug Administration has asked a panel of its advisors to reassess the drug’s effectiveness. The medication’s safety isn’tContinue Reading

FRIDAY, March 3, 2023 (HealthDay News) — Alarmed by the increasing spread of medical misinformation, 50 U.S. medical and science organizations have announced the formation of a new group that aims to debunk fake health news. Called the Coalition for Trust in Health & Science, the group brings together reputableContinue Reading

THURSDAY, March 2, 2023 (HealthDay News) — Black women who are exposed to certain forms of racism may be more likely to develop heart disease, researchers say. Specifically, Black women who said they faced discrimination in employment, housing and in their interactions with the police were 26% more likely toContinue Reading

THURSDAY, March 2, 2023 (HealthDay News) — Following hours of discussion over safety concerns, a U.S. Food and Drug Administration advisory panel on Wednesday recommended approval of a second RSV vaccine, this one made by GlaxoSmithKline, for use in Americans ages 60 and older. The panel’s recommendation was based largelyContinue Reading